Cogentix Medical (NASDAQ: CGNT) reported Q3 EPS of $0.00, $0.01 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $13.8 million versus the consensus estimate of $14.25 million.

For earnings history and earnings-related data on Cogentix Medical (CGNT) click here.